11-23-2017 07:47 AM CET - Health & Medicine
Print

Global Biomarkers Market Worth USD 78.9 Billion till 2024 | Major Players are: Epigenomics AG, Siemens AG, QIAGEN, GE Healthcare

Press release from: Data Bridge Market Research
Biomarkers Market Will be Growing at a CAGR of 12.2% by 2024
Biomarkers Market Will be Growing at a CAGR of 12.2% by 2024


Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brief Sample of the Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Major Market Drivers and Restraints:

• Increase in R&D financing and healthcare expenditure
• Developing number of CROs
• Rising utility of biomarkers for treatment purposes
• Ease in leading clinical trials in developing countries
• High capital ventures and cost-to-profit proportions
• High cost of testing, sample collection, and storage
• Administrative and reimbursement challenges

The market is segmented on the basis of type, technology, application, indication, and geography.

Read more about the report @ databridgemarketresearch.com/reports/global-biomarkers-ma...

Based On Type:
• Consumables
• Services
• Softwares

Based on Technology:
• Efficacy
• Safety
• Validation Biomakers

Based On Application:
• Diagnostics
• Drug Discovery
• Personalized Medicine
• Disease Risk Assessment

Based On Indication:
• Cancer
• Cardiovascular Disorders
• Immunological Disorders

Inquire For TOC: databridgemarketresearch.com/toc/?dbmr=global-biomarkers-...

Based on geography the market is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

Some of the major players operating in this market are
• QIAGEN
• PerkinElmer, Inc.
• Merck & Co.
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• EKF Diagnostics Holdings Plc
• Abbott
• Siemens AG
• MESO SCALE DIAGOSTICS, LLC
• Agilent Technologies
• Singulex, Inc.
• Cisbio Bioassays
• Thermo Fisher Scientific Inc.
• Bruker
• Biosims Technologies
• Epigenomics AG
• Signosis, Inc.
• GE Healthcare

Talk to the Industry Experts: http:/databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biomarkers-market

Table Of Content:

1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

1.2.MARKET SEGMENTATION & COVERAGE

1.2.1.CURRENCY AND PRICING

1.2.2.LIMITATION

1.2.3.STAKEHOLDERS

2.RESEARCH METHODOLOGY

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.DATA TRIANGULATION

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.PRODUCT PIPELINE ANALYSIS

2.2.6.PORTER’S FIVE FORCES MATRIX

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET LANDSCAPE SUMMARY

4.PREMIUM INSIGHTS

4.1.OVERVIEW

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

4.3.MARKET OVERVIEW

4.3.1.DRIVERS

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

4.3.1.2.NON-INVASIVE

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

4.3.1.4.GROWING NUMBER OF CROs

4.3.2.RESTRAINTS

4.3.3.OPPURTUNITIES

4.3.4.THREATS

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.EXECUTIVE SUMMARY

6.BIOMARKERS MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.CONSUMABLES,

6.3.SERVICES,

6.4.SOFTWARE,

7.BIOMARKERS MARKET, BY TECHNOLOGY

7.1.OVERVIEW

7.2.SAFETY BIOMARKERS

7.3.EFFICACY BIOMARKERS

7.4.VALIDATION BIOMARKERS

8.BIOMARKERS MARKET, BY APPLICATION

8.1. OVERVIEW

8.2. DIAGNOSTICS DEVELOPMENT

8.3. DRUG DISCOVERY AND DEVELOPMENT

8.4. PERSONALIZED MEDICINE

8.5 DISEASE-RISK ASSESSMENT

8.6. OTHERS

9.BIOMARKERS MARKET, BY INDICATION

9.1.OVERVIEW

9.2.CANCER

9.3.CARDIOVASCULAR DISORDERS

9.4.NEUROLOGICAL DISORDERS

9.5.IMMUNOLOGICAL DISORDERS

9.6.OTHER DISEASES

10.BIOMARKERS MARKET, BY GEOGRAPHY

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1.NORTH AMERICA

10.1.1.1.U.S.

10.1.1.2.CANADA

10.1.1.3.MEXICO

10.1.2.EUROPE

10.1.2.1.GERMANY

10.1.2.2.FRANCE

10.1.2.3.U.K.

10.1.2.4.ITALY

10.1.2.5.SPAIN

10.1.2.6.RUSSIA

10.1.2.7.TURKEY

10.1.2.8.BELGIUM

10.1.2.9.NETHERLANDS

10.1.2.10.SWITZERLAND

10.1.2.11.REST OF EUROPE

10.1.3.ASIA-PACIFIC (APAC)

10.1.3.1.JAPAN

10.1.3.2.CHINA

10.1.3.3.SOUTH KOREA

10.1.3.4.INDIA

10.1.3.5.AUSTRALIA

10.1.3.6.SINGAPORE

10.1.3.7.THAILAND

10.1.3.8.MALAYSIA

10.1.3.9.INDONESIA

10.1.3.10.PHILIPPINES

10.1.3.11.REST OF APAC

10.1.4.LATIN AMERICA

10.1.4.1.BRAZIL

10.1.4.2.REST OF LATIN AMERICA

10.1.5.MIDDLE EAST AND AFRICA

10.1.5.1.SOUTH AFRICA

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.7.MERGERS & ACQUISITIONS

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

11.9.EXPANSIONS

11.10.REGULATORY CHANGES

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12.BIOMARKERS MARKET, COMPANY PROFILES

12.1.QIAGEN N.V

12.1.1.COMPANY OVERVIEW

12.1.2.SWOT ANALYSIS

12.1.3.REVENUE ANALYSIS

12.1.4.PRODUCT PORTFOLIO

12.1.5.RECENT DEVELOPEMENTS

12.1.6.DATA BRIDGE ANALYSIS

12.2.PERKINELMER, INC

12.2.1.COMPANY OVERVIEW

12.2.2.SWOT ANALYSIS

12.2.3.REVENUE ANALYSIS

12.2.4.PRODUCT PORTFOLIO

12.2.5.RECENT DEVELOPEMENTS

12.2.6.DATA BRIDGE ANALYSIS

12.3.MERCK & CO, INC.

12.3.1.COMPANY OVERVIEW

12.3.2.SWOT ANALYSIS

12.3.3.REVENUE ANALYSIS

12.3.4.PRODUCT PORTFOLIO

12.3.5.RECENT DEVELOPEMENTS

12.3.6.DATA BRIDGE ANALYSIS

12.4.BIO-RAD LABORATORIES

12.4.1.COMPANY OVERVIEW

12.4.2.SWOT ANALYSIS

12.4.3.REVENUE ANALYSIS

12.4.4.PRODUCT PORTFOLIO

12.4.5.RECENT DEVELOPEMENTS

12.4.6.DATA BRIDGE ANALYSIS

12.5.ENZO BIOCHEM, INC.,

12.5.1.COMPANY OVERVIEW

12.5.2.SWOT ANALYSIS

12.5.3.REVENUE ANALYSIS

12.5.4.PRODUCT PORTFOLIO

12.5.5.RECENT DEVELOPEMENTS

12.5.6.DATA BRIDGE ANALYSIS

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

12.6.1.COMPANY OVERVIEW

12.6.2.SWOT ANALYSIS

12.6.3.REVENUE ANALYSIS

12.6.4.PRODUCT PORTFOLIO

12.6.5.RECENT DEVELOPEMENTS

12.6.6.DATA BRIDGE ANALYSIS

12.7.MESO SCALE DIAGNOSTICS

12.7.1.COMPANY OVERVIEW

12.7.2.SWOT ANALYSIS

12.7.3.REVENUE ANALYSIS

12.7.4.PRODUCT PORTFOLIO

12.7.5.RECENT DEVELOPEMENTS

12.7.6.DATA BRIDGE ANALYSIS

12.8.LLC, SINGULEX, INC.,

12.8.1.COMPANY OVERVIEW

12.8.2.SWOT ANALYSIS

12.8.3.REVENUE ANALYSIS

12.8.4.PRODUCT PORTFOLIO

12.8.5.RECENT DEVELOPEMENTS

12.8.6.DATA BRIDGE ANALYSIS

12.9.CISBIO BIOASSAYS

12.9.1.COMPANY OVERVIEW

12.9.2.SWOT ANALYSIS

12.9.3.REVENUE ANALYSIS

12.9.4.PRODUCT PORTFOLIO

12.9.5.RECENT DEVELOPEMENTS

12.9.6.DATA BRIDGE ANALYSIS

12.10.BIOSIMS TECHNOLOGIES

12.10.1.COMPANY OVERVIEW

12.10.2.SWOT ANALYSIS

12.10.3.REVENUE ANALYSIS

12.10.4.PRODUCT PORTFOLIO

12.10.5.RECENT DEVELOPEMENTS

12.10.6.DATA BRIDGE ANALYSIS

12.11. SIGNOSIS, INC.

12.11.1.COMPANY OVERVIEW

12.11.2.SWOT ANALYSIS

12.11.3.REVENUE ANALYSIS

12.11.4.PRODUCT PORTFOLIO

12.11.5.RECENT DEVELOPEMENTS

12.11.6.DATA BRIDGE ANALYSIS

13.APPENDIX

14.ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: databridgemarketresearch.com/reports/global-drug-delivery...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 829595 • Views: 125
More releasesMore releases

You can edit or delete your press release here: